Home
/
NowPatient Blog
/
Intermittent Energy Restriction Diet & How Can It Help With My Weight Loss

Intermittent Energy Restriction Diet & How Can It Help With My Weight Loss

Navin Khosla NowPatientGreen tick
Created on 28 Dec 2023
Updated on 16 Jul 2024

Obesity, defined by an elevated body mass index (BMI) due to excessive or abnormal accumulation of fat, is a global health concern. With the prevalence of obesity increasing worldwide, it has become crucial to find effective strategies for weight loss and improving metabolic health benefits. Dietary interventions are considered the first-line treatment for obese individuals, and one such strategy is intermittent energy restriction (IER).

Intermittent energy restriction involves intermittent pauses in eating, achieved through different variations such as alternate-day fasting (ADF) and time-restricted feeding (TRF). Numerous studies have shown that IER diets can be effective for weight loss and have beneficial effects on various metabolic parameters, including insulin sensitivity, lipid profile, and blood pressure. In addition, IER diets are comparable to continuous energy restriction (CER) diets in terms of weight loss and metabolic improvements.

This article aims to provide an in-depth analysis of the benefits and effects of intermittent fasting for weight loss and health. We will explore the influence of IER on body mass, fat mass, insulin sensitivity, lipid profile, gut microbiota, inflammation, hypertension, and other molecular mechanisms. We will also discuss adherence to IER diets, and potential side effects, and compare IER to CER diets. Finally, we will highlight the current limitations of knowledge on IER and suggest future directions for research in this field.

Understanding Obesity

Obesity is a complex disease characterized by an elevated BMI, which is the result of excess or abnormal accumulation of fat. It is a major risk factor for various chronic conditions, including type 2 diabetes, hypertension, cardiovascular disease, and certain types of cancer. Adipose tissue, which consists of adipocytes and other cells, plays a crucial role in regulating energy balance and metabolic homeostasis. Excessive adipose tissue can lead to dysfunction and the release of inflammatory factors, contributing to insulin resistance and other metabolic disorders.

The Concept of Intermittent Energy Restriction (IER)

Dietary interventions are essential for the management of obesity, and the primary goal is caloric restriction and subsequent weight loss. Intermittent energy restriction diet (IER) or intermittent fasting is a type of diet that involves intermittent pauses in eating, achieved through different variations such as alternate-day fasting (ADF) and time-restricted feeding (TRF). ADF consists of alternating fasting days with severe energy intake restriction and subsequent feed days without caloric intake restriction. TRF involves food intake consumption within restricted hours of the day, with variations in the duration of the fasting period.

This approach to dieting has gained popularity due to its potential benefits for weight loss and metabolic health. Fasting periods during IER diets induce the expenditure of glucose and glycogen, leading to a shift in energy metabolism from glucose to fat-derived ketone bodies and free fatty acids. Fatty acids and glycerol become the main sources of energy during fasting, with the liver converting fatty acids into ketone bodies for use by the brain. Fasting also leads to improvements in glucose regulation, abdominal fat loss, and regulation of cardiometabolic parameters.

The Influence of IER on Humans

Body Mass, Fat Mass, and Ectopic Fat

Weight loss is a primary goal of dietary interventions for obesity, with a focus on reducing fat mass while preserving fat-free mass and improving body composition. Several clinical trials have demonstrated the effectiveness of IER diets, including ADF and TRF, in reducing body weight. The reduction in body weight changes among IER diet groups is commonly reported to be around 5 kg after 10-12 weeks of intervention. Shorter or longer durations of study have resulted in smaller or greater weight losses, respectively.

IER diets have also been found to induce reductions in fat mass while preserving fat-free mass. ADF diets have shown significant reductions in fat mass among obese patients. TRF diets have also been associated with reductions in body weight and fat mass among overweight individuals. In addition, IER regimens have shown potential benefits in reducing ectopic fat, which is the accumulation of fat in non-adipose tissues such as the liver and skeletal muscle.

Insulin Sensitivity and Glucose Tolerance

Obesity is often associated with insulin resistance, a condition in which the body’s cells become less responsive to insulin, leading to elevated blood glucose levels. IER diets have shown promising effects on insulin sensitivity and glucose tolerance. Studies have reported reductions in fasting insulin levels and improvements in insulin sensitivity among participants on IER regimens. Some studies have also observed reductions in fasting glucose levels among individuals following IER diets. The impact of IER on insulin and glucose levels may vary depending on factors such as sex and the timing of eating intervals.

Lipid Profile

IER regimens have been found to have beneficial effects on plasma lipid levels. Studies have reported reductions in triglyceride and LDL cholesterol levels, as well as improvements in HDL cholesterol levels. IER diets have also been associated with an increase in LDL particle size, which is important for reducing cardiovascular risk. However, the impact of IER on lipid profiles may vary depending on the specific diet and duration of intervention.

Gut Microbiota

Emerging research suggests that IER diets can influence the composition of the gut microbiota, which plays a crucial role in metabolic health. Studies have found that IER, such as fasting during the Muslim holy month of Ramadan, can lead to changes in the gut microbiota, including increased levels of beneficial bacteria and improved microbial richness and diversity. These changes in the gut microbiota may contribute to the metabolic benefits observed with IER diets.

Biomarkers of Inflammation

Chronic low-grade inflammation is a common feature of obesity and is associated with various metabolic disorders. Some studies have found that IER regimens can reduce levels of inflammatory biomarkers, such as C-reactive protein (CRP), particularly in overweight and obese adults. However, the effects of IER on other inflammatory markers, such as tumour necrosis factor-α and interleukin-6, have been inconsistent.

Hypertension

Hypertension, or high blood pressure, is a common comorbidity of obesity and is a significant risk factor for cardiovascular disease. IER regimens have been found to have a particular ability to decrease systolic and/or diastolic blood pressure. Several studies have reported significant reductions in blood pressure among individuals following IER diets. The mechanisms through which IER lowers blood pressure are not fully understood but may involve improved vascular endothelial function.

Other Molecular Mechanisms

IER diets may influence various molecular mechanisms involved in metabolism and ageing. Animal studies have shown that IER can improve insulin sensitivity, reduce inflammation, increase stress resistance, and enhance cellular recycling processes. These effects may be mediated by the activation of specific pathways and the production of various proteins.

Adherence to IER Diets

Adherence to dietary interventions is crucial for achieving successful weight loss and metabolic improvements. Short-term studies have reported low dropout rates among individuals following IER diets. TRF diets with 8-12 hours of fasting have been well-tolerated by participants, with high compliance rates reported. Longer fasting periods have also been associated with greater adherence. Further research with longer-term interventions and follow-up is needed to assess long-term adherence to IER diets.

Side Effects of IER Diets

Side effects of IER diets are generally rare and mild. Some individuals may experience morning fatigue, headaches, changes in appetite, irritability, and dizziness during the initial days of dietary intervention. Individuals with diabetes who are on hypoglycemic drugs may be at increased risk of hypoglycemia when following IER diets. It is important to monitor blood glucose levels and adjust medication doses accordingly.

Comparison to Continuous Energy Restriction (CER) Diet

Several studies have compared the effects of IER and CER diets on weight loss and metabolic health. In most cases, both IER and CER diets are equally effective for weight loss and metabolic improvements. The daily calorie restriction in IER diets is often comparable to CER diets, with similar reductions in body weight and improvements in metabolic parameters observed. However, some studies have reported differences in weight loss between IER and CER diets, with some favouring one approach over the other. More research is needed to understand the factors that may influence the differential effects of IER and CER diets.

Alternate-Day Fasting (ADF)

Alternate-day fasting is a form of IER that involves alternating fasting days with days of normal eating. On fasting days, individuals consume only a fraction of their usual calorie intake, typically around 25% of their daily energy expenditure needs. On non-fasting days, individuals are allowed to eat freely without any specific restrictions. This pattern of fasting and feasting creates a calorie deficit that can lead to weight loss over time.

Time-Restricted Feeding (TRF)

Time-restricted feeding is another form of IER that involves limiting the daily eating window to a specific period, typically 8-10 hours. Outside of this eating window, individuals fast and consume no calories. This approach is often referred to as the 16:8 fasting method, where individuals fast for 16 hours and consume all their meals within an 8-hour window. By restricting the eating window, TRF helps to create a calorie deficit and promote weight loss.

Implementing Intermittent Energy Restriction

If you’re considering trying intermittent energy restriction as a weight loss strategy, it’s essential to approach it safely and sustainably. Here are some key tips to keep in mind:

Consult a Healthcare Professional

Before embarking on any dietary changes, it’s crucial to consult with a healthcare professional, especially if you have any underlying health conditions or are taking medication. They can provide personalised guidance and ensure that intermittent energy restriction is suitable for you.

Choose the Right IER Method

There are various forms of intermittent energy restriction, so it’s essential to choose the method that aligns with your lifestyle and preferences. Whether you opt for alternate-day fasting or time-restricted feeding, select an approach that you can adhere to in the long term.

Plan Your Meals

Proper meal planning is key to success with intermittent energy restriction. On fasting days, ensure that you have low-calorie, nutrient-dense foods readily available. On non-fasting days, focus on consuming a balanced diet consisting of carbohydrates, proteins and fats that meet your nutritional needs. Dietary education from a qualified dietitian may be useful.

Stay Hydrated

During fasting periods, it’s crucial to stay hydrated. Drink plenty of water throughout the day to support your overall health and well-being. Hydration can also help curb hunger pangs and keep you feeling satisfied.

Listen to Your Body

Pay attention to how your body responds to intermittent energy restriction. If you experience any adverse effects or discomfort, adjust your approach accordingly. It’s essential to prioritise your health and well-being above all else.

Conclusion

Intermittent energy restriction (IER) diets, such as alternate-day fasting (ADF) and time-restricted feeding (TRF), have emerged as effective strategies for weight loss, weight management and improving metabolic health. These diets have been found to reduce body weight, and body fat, and improve insulin sensitivity, lipid profile, and blood pressure. Adherence to IER diets is generally high, and side effects are rare and mild. IER diets have been compared to continuous energy restriction (CER) diets and have shown similar effectiveness in promoting weight loss and metabolic improvements. However, further research is needed to understand the long-term effects and safety of IER diets, as well as the specific populations that may benefit the most from this approach. Overall, IER diets offer a viable alternative for individuals who may struggle with traditional continuous dietary restrictions.

References:

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Now Patient Data Security

Data Security

Our Commitment to You.

Learn moreNow Patient Data SecurityNow Patient Data Security

WHY WE BUILT NOWPATIENT

We are committed to helping everyone, everywhere live healthier lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

NowPatient dashboard

Your Questions Answered

For your peace of mind, we can answer your questions quickly

What does NowPatient do?

NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.

Get started today and benefit from medication remindersGet Treated PrivatelyNHS online pharmacyGP appointment bookingRx savings cardDrug CouponsUS drug savings programshealth conditions informationgenetic testinghome test kitsBMI RisksType 2 Diabetes Riskspollen meterair quality monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.

UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.

US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

We do not provide any prescribing services or dispensing services in the United States.

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111

Find more answers